Works by Paludo, Jonas
Results: 64
Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01173-w
- By:
- Publication type:
- Article
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
- By:
- Publication type:
- Article
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00895-7
- By:
- Publication type:
- Article
Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00777-4
- By:
- Publication type:
- Article
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
- Published in:
- 2022
- By:
- Publication type:
- Letter
The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00394-z
- By:
- Publication type:
- Article
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
- By:
- Publication type:
- Article
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
- By:
- Publication type:
- Article
CT-387: Prognostic Role of Lymphocyte to Monocyte Ratio in Pts Treated with CAR-T for Aggressive Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S453, doi. 10.1016/S2152-2650(21)02005-X
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: CT-387: Prognostic Role of Lymphocyte to Monocyte Ratio in Pts Treated with CAR-T for Aggressive Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S258, doi. 10.1016/S2152-2650(21)01622-0
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
Outcome of Very Young (≤ 40 Years) Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Case Control Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e89, doi. 10.1016/j.clml.2017.03.159
- By:
- Publication type:
- Article
Myelomatous Involvement of the Central Nervous System.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1808, doi. 10.3390/biomedicines12081808
- By:
- Publication type:
- Article
Day 100 Natural Killer Cell/CD14+HLA‐DR<sup>DIM</sup> ratio and survival in lymphoma post‐autologous peripheral blood hematopoietic stem cell transplantation.
- Published in:
- Clinical Transplantation, 2024, v. 38, n. 1, p. 1, doi. 10.1111/ctr.15211
- By:
- Publication type:
- Article
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01256-w
- By:
- Publication type:
- Article
Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9228, doi. 10.1002/cam4.5665
- By:
- Publication type:
- Article
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 20, p. 3287, doi. 10.3390/cells11203287
- By:
- Publication type:
- Article
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
- By:
- Publication type:
- Article
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
- By:
- Publication type:
- Article
Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 658, doi. 10.1002/hon.2919
- By:
- Publication type:
- Article
Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Exploring Gene Expression Profiles in Primary Central Nervous System Vasculitis.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 1, p. 120, doi. 10.1002/ana.26537
- By:
- Publication type:
- Article
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
- By:
- Publication type:
- Article
Reply to Castillo et al.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. E71, doi. 10.1002/ajh.25029
- By:
- Publication type:
- Article
Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E47, doi. 10.1002/ajh.24971
- By:
- Publication type:
- Article
<italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
- By:
- Publication type:
- Article
Long‐term outcome of immunologic autograft engineering.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 488, doi. 10.1002/jha2.404
- By:
- Publication type:
- Article
Chimeric antigen receptor T‐cell therapy in hematologic malignancies: Successes, challenges, and opportunities.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 2, p. 197, doi. 10.1111/ejh.14074
- By:
- Publication type:
- Article
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 48, doi. 10.1111/ejh.13609
- By:
- Publication type:
- Article
Mantle cell lymphoma: a great masquerader.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Growing Role of Digital Health Tools in the Care of Patients with Cancer: Current Use, Future Opportunities, and Barriers to Effective Implementation.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 6, p. 593, doi. 10.1007/s11912-024-01534-5
- By:
- Publication type:
- Article
Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Waldenström macroglobulinemia: biology, genetics, and therapy.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2016, v. 6, p. 49, doi. 10.2147/BLCTT.S84157
- By:
- Publication type:
- Article
Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.
- Published in:
- Leukemia & Lymphoma, 2024, v. 65, n. 3, p. 389, doi. 10.1080/10428194.2023.2285236
- By:
- Publication type:
- Article
Central nervous system involvement by mantle cell lymphoma.
- Published in:
- Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 371, doi. 10.1080/10428194.2022.2148211
- By:
- Publication type:
- Article
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 12, p. 2879, doi. 10.1080/10428194.2022.2102623
- By:
- Publication type:
- Article
Impact of autograft-absolute lymphocyte count on survival in double/triple hit lymphomas post-autologous stem cell transplantation.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 10, p. 2436, doi. 10.1080/10428194.2022.2064988
- By:
- Publication type:
- Article
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 6, p. 1363, doi. 10.1080/10428194.2022.2030475
- By:
- Publication type:
- Article
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 308, doi. 10.1080/10428194.2020.1832669
- By:
- Publication type:
- Article
Predictors of short-term survival in Waldenström Macroglobulinemia.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Non-tender recurrent scrotal cellulitis.
- Published in:
- 2018
- By:
- Publication type:
- journal article